The global ureteroscopy market was valued at $807.34 million in 2021, and is projected to reach $1,379.82 million by 2031, registering a CAGR of 5.5% from 2022 to 2031.
Ureteroscopy is a procedure used to diagnose and treat a wide range of urinary tract issues. A tiny scope (like flexible telescope) is introduced into the bladder and ureter. Ureteroscopy is an examination of the upper urinary tract and performed with an ureteroscope which is inserted directly into the ureter after passing through the urethra and bladder. This procedure is useful in the diagnosis and treatment of disorders such as kidney stones and urothelial carcinoma of the upper urinary tract. The procedure typically takes one to three hours to complete and is usually done while the patient is under general anesthesia.
The growth of the global ureteroscopy market is majorly driven by rise in technological advancement and increase in prevalence of urological diseases such as kidney cancer and kidney stone that require ureteroscopy devices and are the major factors that boost the market growth. Furthermore, increased medical demands in the developing countries such as India and China and growth opportunities in emerging markets are expected to create immense opportunities for the ureteroscopy market during the forecast period.
However, the high cost associated with the ureteroscopes hinders the growth of the market. Moreover, clinical barriers for ureteroscopes and risk of infection act as major restraints for the global ureteroscopy market. Conversely, increase in healthcare expenditure and rise in number of specialized hospitals & clinics in countries such as China and India are expected to create lucrative opportunities for the growth of the market.
The global ureteroscopy market is segmented into product, application, end user, and region. By product, the market is categorized into flexible ureteroscope and semi-rigid ureteroscope. On the basis of application, the market is segregated into urolithiasis, kidney cancer, urinary stricture, and others. According to end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global ureteroscopy market are Advin Health Care, Boston Scientific Corporation, Cliniva Healthcare, Hoya Corporation, KARL STORZ SE & Co. KG, Olympus Corporation, OTU Medical, Richard Wolf GmbH, STERIS plc, and Stryker Corporation.
Ureteroscopy is a procedure used to diagnose and treat a wide range of urinary tract issues. A tiny scope (like flexible telescope) is introduced into the bladder and ureter. Ureteroscopy is an examination of the upper urinary tract and performed with an ureteroscope which is inserted directly into the ureter after passing through the urethra and bladder. This procedure is useful in the diagnosis and treatment of disorders such as kidney stones and urothelial carcinoma of the upper urinary tract. The procedure typically takes one to three hours to complete and is usually done while the patient is under general anesthesia.
The growth of the global ureteroscopy market is majorly driven by rise in technological advancement and increase in prevalence of urological diseases such as kidney cancer and kidney stone that require ureteroscopy devices and are the major factors that boost the market growth. Furthermore, increased medical demands in the developing countries such as India and China and growth opportunities in emerging markets are expected to create immense opportunities for the ureteroscopy market during the forecast period.
However, the high cost associated with the ureteroscopes hinders the growth of the market. Moreover, clinical barriers for ureteroscopes and risk of infection act as major restraints for the global ureteroscopy market. Conversely, increase in healthcare expenditure and rise in number of specialized hospitals & clinics in countries such as China and India are expected to create lucrative opportunities for the growth of the market.
The global ureteroscopy market is segmented into product, application, end user, and region. By product, the market is categorized into flexible ureteroscope and semi-rigid ureteroscope. On the basis of application, the market is segregated into urolithiasis, kidney cancer, urinary stricture, and others. According to end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global ureteroscopy market are Advin Health Care, Boston Scientific Corporation, Cliniva Healthcare, Hoya Corporation, KARL STORZ SE & Co. KG, Olympus Corporation, OTU Medical, Richard Wolf GmbH, STERIS plc, and Stryker Corporation.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ureteroscopy market analysis from 2021 to 2031 to identify the prevailing ureteroscopy market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the ureteroscopy market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global ureteroscopy market trends, key players, market segments, application areas, and market growth Strategies.
Key Market Segments
By Product
- Flexible Ureteroscope
- Semi- Rigid Ureteroscope
By Application
- Urolithiasis
- Kidney Cancer
- Urinary Stricture
By End User
- Hospitals
- Ambulatory Surgical Centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- KARL STORZ SE & Co. KG
- Hoya Corporation
- Stryker Corporation
- Boston Scientific Corporation
- Advin Health Care
- Cliniva Healthcare
- Olympus Corporation
- OTU Medical
- Richard Wolf GmbH
- STERIS plc
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. High bargaining power of suppliers
3.3.2. High bargaining power of buyers
3.3.3. High threat of substitutes
3.3.4. High threat of new entrants
3.3.5. Moderate intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of urological diseases
3.4.1.2. Increase in number of urological surgeries
3.4.1.3. Increase in demand for ureteroscopes
3.4.2. Restraints
3.4.2.1. Side effects of ureteroscopes
3.4.2.2. High cost of digital ureteroscopes
3.4.3. Opportunities
3.4.3.1. Rise in technological advancements
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: URETEROSCOPY MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Flexible Ureteroscope
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Semi- Rigid Ureteroscope
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: URETEROSCOPY MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Urolithiasis
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Kidney Cancer
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Urinary Stricture
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: URETEROSCOPY MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory Surgical Centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: URETEROSCOPY MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. Australia
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. India
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Product
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Product
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Advin Health Care
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. Boston Scientific Corporation
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Cliniva Healthcare
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.4. KARL STORZ SE & Co. KG
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Olympus Corporation
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. OTU Medical
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Hoya Corporation
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. Richard Wolf GmbH
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. STERIS plc
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Stryker Corporation
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
List of Tables
Table 01. Global Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 02. Ureteroscopy Market for Flexible Ureteroscope, by Region, 2021-2031 (Revenue, $Million)
Table 03. Ureteroscopy Market for Semi- Rigid Ureteroscope, by Region, 2021-2031 (Revenue, $Million)
Table 04. Global Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 05. Ureteroscopy Market for Urolithiasis, by Region, 2021-2031 (Revenue, $Million)
Table 06. Ureteroscopy Market for Kidney Cancer, by Region, 2021-2031 (Revenue, $Million)
Table 07. Ureteroscopy Market for Urinary Stricture, by Region, 2021-2031 (Revenue, $Million)
Table 08. Ureteroscopy Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 09. Global Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 10. Ureteroscopy Market for Hospitals, by Region, 2021-2031 (Revenue, $Million)
Table 11. Ureteroscopy Market for Ambulatory Surgical Centers, by Region, 2021-2031 (Revenue, $Million)
Table 12. Ureteroscopy Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 13. Ureteroscopy Market, by Region, 2021-2031 (Revenue, $Million)
Table 14. North America Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 15. North America Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 16. North America Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 17. North America Ureteroscopy Market, by Country, 2021-2031 (Revenue, $Million)
Table 18. U.S. Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 19. U.S. Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 20. U.S. Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 21. Canada Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 22. Canada Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 23. Canada Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 24. Mexico Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 25. Mexico Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 26. Mexico Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 27. Europe Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 28. Europe Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 29. Europe Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 30. Europe Ureteroscopy Market, by Country, 2021-2031 (Revenue, $Million)
Table 31. Germany Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 32. Germany Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 33. Germany Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 34. France Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 35. France Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 36. France Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 37. UK Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 38. UK Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 39. UK Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 40. Italy Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 41. Italy Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 42. Italy Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 43. Spain Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 44. Spain Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 45. Spain Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 46. Rest of Europe Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 47. Rest of Europe Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 48. Rest of Europe Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 49. Asia-Pacific Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 50. Asia-Pacific Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 51. Asia-Pacific Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 52. Asia-Pacific Ureteroscopy Market, by Country, 2021-2031 (Revenue, $Million)
Table 53. Japan Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 54. Japan Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 55. Japan Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 56. China Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 57. China Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 58. China Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 59. Australia Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 60. Australia Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 61. Australia Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 62. India Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 63. India Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 64. India Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 65. South Korea Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 66. South Korea Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 67. South Korea Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 68. Rest of Asia-Pacific Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 69. Rest of Asia-Pacific Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 70. Rest of Asia-Pacific Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 71. LAMEA Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 72. LAMEA Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 73. LAMEA Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 74. LAMEA Ureteroscopy Market, by Country, 2021-2031 (Revenue, $Million)
Table 75. Brazil Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 76. Brazil Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 77. Brazil Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 78. Saudi Arabia Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 79. Saudi Arabia Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 80. Saudi Arabia Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 81. South Africa Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 82. South Africa Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 83. South Africa Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 84. Rest of LAMEA Ureteroscopy Market, by Product, 2021-2031 (Revenue, $Million)
Table 85. Rest of LAMEA Ureteroscopy Market, by Application, 2021-2031 (Revenue, $Million)
Table 86. Rest of LAMEA Ureteroscopy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 87. Advin Health Care: Key Executives
Table 88. Advin Health Care: Company Snapshot
Table 89. Advin Health Care: Product Segments
Table 90. Advin Health Care: Product Portfolio
Table 91. Boston Scientific Corporation: Key Executives
Table 92. Boston Scientific Corporation: Company Snapshot
Table 93. Boston Scientific Corporation: Product Segments
Table 94. Boston Scientific Corporation: Product Portfolio
Table 95. Cliniva Healthcare: Key Executives
Table 96. Cliniva Healthcare: Company Snapshot
Table 97. Cliniva Healthcare: Product Segments
Table 98. Cliniva Healthcare: Product Portfolio
Table 99. Karl Storz SE & Co. KG: Key Executives
Table 100. Karl Storz SE & Co. KG: Company Snapshot
Table 101. Karl Storz SE & Co. KG: Product Segments
Table 102. Karl Storz SE & Co. KG: Product Portfolio
Table 103. Olympus Corporation: Key Executives
Table 104. Olympus Corporation: Company Snapshot
Table 105. Olympus Corporation: Product Segments
Table 106. Olympus Corporation: Product Portfolio
Table 107. Otu Medical: Key Executives
Table 108. Otu Medical: Company Snapshot
Table 109. Otu Medical: Product Segments
Table 110. Otu Medical: Product Portfolio
Table 111. Hoya Corporation: Key Executives
Table 112. Hoya Corporation: Company Snapshot
Table 113. Hoya Corporation: Product Segments
Table 114. Hoya Corporation: Product Portfolio
Table 115. Richard Wolf GmbH: Key Executives
Table 116. Richard Wolf GmbH: Company Snapshot
Table 117. Richard Wolf GmbH: Product Segments
Table 118. Richard Wolf GmbH: Product Portfolio
Table 119. Steris PLC: Key Executives
Table 120. Steris PLC: Company Snapshot
Table 121. Steris PLC: Product Segments
Table 122. Steris PLC: Product Portfolio
Table 123. Stryker Corporation: Key Executives
Table 124. Stryker Corporation: Company Snapshot
Table 125. Stryker Corporation: Product Segments
Table 126. Stryker Corporation: Product Portfolio
List of Figures
Figure 01. Ureteroscopy Market, 2021-2031
Figure 02. Segmentation of Ureteroscopy Market, 2021-2031
Figure 03. Top Investment Pockets in Ureteroscopy Market (2022-2031)
Figure 04. High Bargaining Power of Suppliers
Figure 05. High Bargaining Power of Buyers
Figure 06. High Threat of Substitutes
Figure 07. High Threat of New Entrants
Figure 08. Moderate Intensity of Rivalry
Figure 09. Drivers, Restraints and Opportunities: Globalureteroscopy Market
Figure 10. Ureteroscopy Market, by Product, 2021(%)
Figure 11. Comparative Share Analysis of Ureteroscopy Market for Flexible Ureteroscope, by Country 2021-2031(%)
Figure 12. Comparative Share Analysis of Ureteroscopy Market for Semi- Rigid Ureteroscope, by Country 2021-2031(%)
Figure 13. Ureteroscopy Market, by Application, 2021(%)
Figure 14. Comparative Share Analysis of Ureteroscopy Market for Urolithiasis, by Country 2021-2031(%)
Figure 15. Comparative Share Analysis of Ureteroscopy Market for Kidney Cancer, by Country 2021-2031(%)
Figure 16. Comparative Share Analysis of Ureteroscopy Market for Urinary Stricture, by Country 2021-2031(%)
Figure 17. Comparative Share Analysis of Ureteroscopy Market for Others, by Country 2021-2031(%)
Figure 18. Ureteroscopy Market, by End-user, 2021(%)
Figure 19. Comparative Share Analysis of Ureteroscopy Market for Hospitals, by Country 2021-2031(%)
Figure 20. Comparative Share Analysis of Ureteroscopy Market for Ambulatory Surgical Centers, by Country 2021-2031(%)
Figure 21. Comparative Share Analysis of Ureteroscopy Market for Others, by Country 2021-2031(%)
Figure 22. Ureteroscopy Market by Region, 2021
Figure 23. U.S. Ureteroscopy Market, 2021-2031 ($Million)
Figure 24. Canada Ureteroscopy Market, 2021-2031 ($Million)
Figure 25. Mexico Ureteroscopy Market, 2021-2031 ($Million)
Figure 26. Germany Ureteroscopy Market, 2021-2031 ($Million)
Figure 27. France Ureteroscopy Market, 2021-2031 ($Million)
Figure 28. UK Ureteroscopy Market, 2021-2031 ($Million)
Figure 29. Italy Ureteroscopy Market, 2021-2031 ($Million)
Figure 30. Spain Ureteroscopy Market, 2021-2031 ($Million)
Figure 31. Rest of Europe Ureteroscopy Market, 2021-2031 ($Million)
Figure 32. Japan Ureteroscopy Market, 2021-2031 ($Million)
Figure 33. China Ureteroscopy Market, 2021-2031 ($Million)
Figure 34. Australia Ureteroscopy Market, 2021-2031 ($Million)
Figure 35. India Ureteroscopy Market, 2021-2031 ($Million)
Figure 36. South Korea Ureteroscopy Market, 2021-2031 ($Million)
Figure 37. Rest of Asia-Pacific Ureteroscopy Market, 2021-2031 ($Million)
Figure 38. Brazil Ureteroscopy Market, 2021-2031 ($Million)
Figure 39. Saudi Arabia Ureteroscopy Market, 2021-2031 ($Million)
Figure 40. South Africa Ureteroscopy Market, 2021-2031 ($Million)
Figure 41. Rest of LAMEA Ureteroscopy Market, 2021-2031 ($Million)
Figure 42. Top Winning Strategies, by Year
Figure 43. Top Winning Strategies, by Development
Figure 44. Top Winning Strategies, by Company
Figure 45. Product Mapping of Top 10 Players
Figure 46. Competitive Dashboard
Figure 47. Competitive Heatmap: Ureteroscopy Market
Figure 48. Top Player Positioning, 2021
Figure 49. Boston Scientific Corporation: Net Sales, 2019-2021 ($Million)
Figure 50. Boston Scientific Corporation: Revenue Share by Segment, 2021 (%)
Figure 51. Boston Scientific Corporation: Revenue Share by Region, 2021 (%)
Figure 52. Olympus Corporation: Net Revenue, 2019-2021 ($Million)
Figure 53. Olympus Corporation: Revenue Share by Segment, 2021 (%)
Figure 54. Olympus Corporation: Revenue Share by Region, 2021 (%)
Figure 55. Hoya Corporation: Net Revenue, 2019-2021 ($Million)
Figure 56. Hoya Corporation: Revenue Share by Segment, 2021 (%)
Figure 57. Steris PLC: Net Sales, 2019-2021 ($Million)
Figure 58. Steris PLC: Revenue Share by Segment, 2021 (%)
Figure 59. Steris PLC: Revenue Share by Region, 2021 (%)
Figure 60. Stryker Corporation: Net Revenue, 2019-2021 ($Million)
Figure 61. Stryker Corporation: Revenue Share by Segment, 2021 (%)
Figure 62. Stryker Corporation: Revenue Share by Region, 2021 (%)
Executive Summary
According to the report titled, 'Ureteroscopy Market,' the ureteroscopy market was valued at $807.34 million in 2021, and is estimated to reach $1,379.82 million by 2031, growing at a CAGR of 5.5% from 2022 to 2031. Ureteroscopy is a procedure used in both diagnosis and therapeutic interventions for upper urinary tract infections, kidney cancer, and urolithiasis. Majorly ureteroscopy is used in the treatment of kidney stones and also to evaluate the other causes of kidney blockage. This procedure is useful in the diagnosis and treatment of disorders such as kidney stones and upper urinary tract infections. The procedure typically takes one to three hours to complete and is usually done while the patient is under general anesthesia. These ureteroscopes are available in flexible ureteroscope and semi-rigid ureteroscope. By using a flexible ureteroscope, physician can examine a stone in the ureter and remove it through ureteroscopes. Semi-rigid ureteroscope is an equipment used for examining the interior of the urinary tract.Key factors driving the growth of the ureteroscopy market include rise in urological surgeries increases the demand for ureteroscopy which, in turn, supports the market growth. The most prevalent infectious disease is urinary tract infection which causes increase in surgeries related to urinary system. In addition, minimally invasive or non-invasive surgical methods are becoming more and more popular among patients worldwide. Minimally invasive surgeries have high success rate. Thus, surgeries employing an ureteroscopes intervention are being favored both by doctors and patients. This is attributed to the advantages of minimally invasive surgeries such as being less painful, shorter hospital stay, and requires short recovery period.
In addition, advantages of semi rigid ureteroscopy such as clear visualization, durable design, and autoclavable design boost the growth of the market. For instance, OES Pro Ureteroscopes is a semi-rigid ureteroscope product of Olympus company which has features such as clear visualization and self-dilating insertion tube with an atraumatic tip design allows easier insertion into tight ureters. Thus, these advanced features in ureteroscopes drive the market growth. An ureteroscopy examines the ureters and kidneys using a specialized ureteroscope with a light on it, and it can be used to diagnose kidney cancer. Thus, increase in prevalence of kidney cancer led to rise in adoption of ureteroscopes for diagnosis which contribute toward the growth of market.
Moreover, rise in spending by population in countries such as the U.S. and Canada further leads to growth of the industry. Furthermore, large number of urological surgeries performed each year led to boost the market growth. In addition, effective manufacturing and distribution network of ureteroscopes devices and presence of major key players, such as OTU Medical, STERIS plc, Boston Scientific Corporation, and Stryker Corporation offering ureteroscopes led to boost the growth of the market. Furthermore, availability of favorable reimbursement policies coupled with growth in preference for minimally invasive procedures thereby boosting the market growth. However, exponential increase in population of Asia-Pacific escalates the prevalence of urological diseases, which in turn, contributes toward the regional market growth.
The market also offers growth opportunities to the key players in the market. High adoption of technologically advanced ureteroscopes due to increase in new technologies such as digital stone removing methods further contributes toward growth of market. For instance, in January 2022, Applaud
Medical, Inc., leader in the treatment of kidney stones, announced that its Acoustic Enhancer technology has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). Acoustic Enhancer technology is developed to be used in conjunction with ureteroscopy with Laser Lithotripsy (URS-LL) for the breakdown of calcium-based urinary stones.
The ureteroscopy market is segmented into product, application, end user, and region. On the basis of product, the market is categorized into flexible ureteroscope and semi-rigid ureteroscope. On the basis of application, urolithiasis, kidney cancer, urinary stricture, and others. On the basis of end user, it is categorized into medical device manufacturer and pharmaceutical companies. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players profiled in the study include Advin Health Care, Boston Scientific Corporation, Cliniva Healthcare, Hoya Corporation, KARL STORZ SE & Co. KG, Olympus Corporation, OTU Medical, Richard Wolf GmbH, STERIS plc, and Stryker Corporation.
Key Market Insights
- By product, the flexible ureteroscope segment was the largest revenue contributor to the market in 2021 and is estimated to reach $1,062.42 million by 2031, with a CAGR of 5.9%.
- By application, the urolithiasis segment dominated the global market in 2021 and is expected to be the fastest-growing segment with a highest CAGR of 6.3% during the forecast period.
- By end user, the hospitals segment dominated the global market in 2021 and is expected to be the fastest-growing segment with a highest CAGR during the forecast period.
- Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 7.2% during the forecast period.
Companies Mentioned
- KARL STORZ SE & Co. KG
- Hoya Corporation
- Stryker Corporation
- Boston Scientific Corporation
- Advin Health Care
- Cliniva Healthcare
- Olympus Corporation
- OTU Medical
- Richard Wolf GmbH
- STERIS plc
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 210 |
| Published | January 2023 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 807.34 million |
| Forecasted Market Value ( USD | $ 1379.82 million |
| Compound Annual Growth Rate | 5.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
